A detailed history of Amh Equity LTD transactions in Scynexis Inc stock. As of the latest transaction made, Amh Equity LTD holds 600,000 shares of SCYX stock, worth $708,000. This represents 1.24% of its overall portfolio holdings.

Number of Shares
600,000
Previous 545,000 10.09%
Holding current value
$708,000
Previous $1.09 Million 17.98%
% of portfolio
1.24%
Previous 1.52%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$1.27 - $2.23 $69,850 - $122,650
55,000 Added 10.09%
600,000 $894,000
Q2 2024

Aug 06, 2024

SELL
$1.4 - $2.77 $161,000 - $318,550
-115,000 Reduced 17.42%
545,000 $1.09 Million
Q1 2024

May 06, 2024

BUY
$1.39 - $2.21 $152,344 - $242,216
109,600 Added 19.91%
660,000 $970,000
Q4 2023

Feb 02, 2024

BUY
$1.56 - $2.24 $492,354 - $706,970
315,612 Added 134.42%
550,400 $1.23 Million
Q3 2023

Nov 06, 2023

SELL
$1.93 - $3.64 $29,359 - $55,371
-15,212 Reduced 6.08%
234,788 $535,000
Q1 2023

May 02, 2023

BUY
$1.15 - $3.0 $287,500 - $750,000
250,000 New
250,000 $750,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $38.5M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Amh Equity LTD Portfolio

Follow Amh Equity LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amh Equity LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amh Equity LTD with notifications on news.